22nd Congress Of The European College Of Neuropsychopharmacology

Main Category: Neurology / Neuroscience
Also Included In: Conferences;  Psychology / Psychiatry;  Schizophrenia
Article Date: 27 May 2009 - 1:00 PDT

email to a friend   printer friendly   opinions  

The 22nd Congress of the European College of Neuropsychopharmacology (ECNP) will be held from 12-16 September 2009 in Istanbul, Turkey.

More than 6,500 clinical and basic scientists such as psychiatrists, neurologists, psychologists and neuroscience researchers from all over the world will attend the ECNP Congress, which is the largest annual high scientific standard congress on mental disorders and neuropsychopharmacology in Europe. Renowned experts from 25 countries will present the latest achievements and breakthroughs in neuropsychopharmacology and related disciplines in both clinical and preclinical settings, as well as discuss the various aspects of pharmacotherapy of brain disorders and their impact on patients´ quality of life.

The scientific programme will comprise, among others, the following topics:

• The future of schizophrenia
  
  
• The role of genetic factors in adult ADHD
  
  
• Is the monoamines involved in shaping conduct disorder?
  
  
• Vaccination for Alzheimer´s disease in dementia
  
  
• Novel treatment for smoking
  
  
• Maternal serotonin
  
  
• Deep Brain Stimulation: new perspectives for treatment
  
  
• News on the NewMood project

Furthermore, the educational update sessions at the congress will deal with the current knowledge on GABA and biomarkers in neuropsychopharmacology, treatment of insomnia, bipolar disorders and schizophrenia, and the new classification systems ICD-11 and DSM-V.

For further information about the provisional scientific programme, please visit the ECNP website: http://www.ecnp.eu

Source:
Sonja Mak
European College of Neuropsychopharmacology

• Additional
• References
• Citations